-
BMS issues letter about omeprazole, Copackaged drug regimen approved for PEPFAR, FDA issues final guidance on nucleic acid tests, Consumers warned about unapproved test kits, Roche issues drug interaction warning.
-
-
HIV physicians and public health officials say the recent discovery of a man in his mid-40s with both rapidly progressing AIDS and a highly resistant strain could portend an ominous turn in the epidemic, particularly in light of evidence that the transmission of antiretroviral resistant HIV is increasing in some cities.
-
While post-exposure prophylaxis (PEP) has been available to medical employees and first responders for years, public health officials have routinely dismissed the possibility of extending PEP to the general public, citing the inefficiency of its use even after potential exposure to HIV from rape.
-
The first guidelines written explicitly for the primary care of HIV patients include two pages about antiretroviral adherence, demonstrating how management of HIV disease increasingly is incorporating behavioral factors with medical practice.
-
The fifth vital sign, pulse oximetry, routinely is used in every emergency department throughout the country to determine the baseline oxygenation of a patient in respiratory distress, to assess a patients response to therapeutic decisions, and to monitor a child during a conscious sedation or resuscitation. It is important to understand how the device functions and the limitations of this routinely used technology.
-
-
-
The Centers for Disease Control and Prevention (CDC) has changed its strategy to help health care providers continue to vaccinate people at risk for developing serious complications of influenza.
-
Survey: Hospitals improving medication safety practices; FDA renews contamination alert on IV catheter flushes; Proposed regs will support e-prescribing for Medicare; Awareness of drug programs for lower-income Americans low; FDA issues safety notices.
